Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial

Affiliations

• ¹ Division of Cardiovascular Medicine, Toho University, Ohashi Medical Center, Meguro-ku, Tokyo, Japan (Y.Y., M.N., R.I.).
• ² Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan (S.Y.).
• ³ National Cerebral and Cardiovascular Center, Suita, Osaka, Japan (S.Y.).
• ⁴ Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Japan (K. Kaikita).
• ⁵ Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan (K. Kaikita).
• ⁶ Department of Cardiology, National Hospital Organization Kyoto Medical Center, Japan (M.A.).
• ⁷ Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan (J.A.).
• ⁸ Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan (T.M.).
• ⁹ Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, Japan (K. Miyauchi).
• ¹⁰ Department of Cardiology, Tokyo Women's Medical University, Shinjuku-ku, Japan (N.H.).
• ¹¹ Cardiovascular Center, Yokohama City University Medical Center, Kanagawa, Japan (K. Kimura).
• ¹² Department of Cardiology, Osaka Police Hospital, Japan (A.H.).
• ¹³ Department of General Medicine and Primary Care, Kumamoto University Hospital, Japan (K. Matsui).
• ¹⁴ Kumamoto University, Japan (H.O.).